Together, these attributes position HCB101 as a differentiated innate immune checkpoint backbone with broad potential for a wide variety of combination strategies across solid tumors and hematologic ...

Scientists at the 2026 ACTRIMS forum meet to assess current approaches and explore new directions for MS research and care.

More than 5,000 medical professionals are in New Orleans for the American Stroke Association International Stroke Conference ...

Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ...

Dubai Science Park, the Middle East's leading science-focused hub, is celebrating two decades of enabling science and nurturing the region's research and development (R&D) landscape to strengthen the ...

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...

“It feels validating to finally graduate with my PhD. It is proof of the skills I have developed, and that the work I have ...

"Our ACCESS trial and other allogeneic HCT research are advancing patient outcomes, evolving clinical practice and enabling a collaborative ecosystem to accelerate how cell therapy can serve all ...

Florida State University’s Office of Research will host the 2026 Festival of the Creative Arts, a campuswide event that ...

Gateshead scientist Daniel Parker, who has Asperger’s syndrome, has completed a PhD at the University of Sunderland, aiming ...

Detailed price information for Microbix Biosystems Inc (MBXBF) from The Globe and Mail including charting and trades.

Gateshead scientist Daniel Parker, who has Asperger’s syndrome, has completed a PhD at the University of Sunderland, aiming to ...